Results 141 to 150 of about 8,855 (217)

Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs. [PDF]

J Neuroendocrinol
Polici M, Caruso D, Masci B, Marasco M, Valanzuolo D, Dell'Unto E, Zerunian M, Campana D, De Santis D, Lamberti G, Iannicelli E, Prosperi D, Annibale B, Laghi A, Panzuto F, Rinzivillo M.   +15 more
europepmc   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

World Journal of Surgery, Volume 50, Issue 8, Page 2071-2076, August 2026.
Matilda Anneback, Priya H. Dedhia, Aimee Di Marco, Els Nieveen van Dijkum, Julie A. Miller, Janice L. Pasieka   +5 more
wiley   +1 more source

Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review. [PDF]

Adv Ther, 2021
Cella D, Evans J, Feuilly M, Neggers S, Van Genechten D, Herman J, Khan MS.   +6 more
europepmc   +1 more source

Pancreatic Cancer—Advances in the Last 50 Years

World Journal of Surgery, Volume 50, Issue 8, Page 2106-2115, August 2026.
S. George Barreto, Anirban Maitra, Eileen M. O'Reilly, Dushyant Sahani, Richard Zheng, Charles J. Yeo   +5 more
wiley   +1 more source

Somatostatin analogs in the treatment of gastrointestinal angiodysplasia bleeding: a systematic review. [PDF]

Gastroenterol Hepatol Bed Bench
Correa TL, Antunes VLJ, Bulhoes E, Bolner G, Martins OC, de Mesquita CF, Fernandes MV, Milioli NJ, Baraldo S.   +8 more
europepmc   +1 more source

Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study. [PDF]

Endocrine, 2021
Kuhn E, Caron P, Delemer B, Raingeard I, Lefebvre H, Raverot G, Cortet-Rudelli C, Desailloud R, Geffroy C, Henocque R, Brault Y, Brue T, Chanson P.   +12 more
europepmc   +1 more source

From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms. [PDF]

Ther Adv Med Oncol
Melhorn P, Mazal P, Wolff L, Kretschmer-Chott E, Raderer M, Kiesewetter B.   +5 more
europepmc   +1 more source

Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story. [PDF]

J Endocrinol Invest
Faggiano A.
europepmc   +1 more source

Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study. [PDF]

Oncologist, 2020
Brighi N, Panzuto F, Modica R, Gelsomino F, Albertelli M, Pusceddu S, Massironi S, Lamberti G, Rinzivillo M, Faggiano A, Spallanzani A, Ferone D, Prinzi N, Rossi RE, Annibale B, Colao AM, Campana D.   +16 more
europepmc   +1 more source